Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial.
An S De VrieseRogier CaluwéHans Van Der MeerschKoen De BoeckDirk De BacquerPublished in: Journal of the American Society of Nephrology : JASN (2021)
Oral Anticoagulation in Hemodialysis, NCT03799822.